Analysts: United Continental is Looking Good and 3 New Opinions Investors Must Read Now

ICON (NASDAQ:ICLR): According to Jefferies, LabCorp (NYSE:LH) has been chosen as a preferred provider for full-service global central laboratory services and biomarker testing by Bristol-Myers (NYSE:BMY), and it should have a minimal impact on ICON plc. The firm has stated that ICON confirmed that the agreement announced today does not change its lab outlook, and Jefferies reiterates its Buy rating on ICON, whose shares have dropped 3 percent to $31.40 after LabCorp’s announcement.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ICLR

More Articles About:   , , , , , ,